The epidemiology of nosocomial infections caused by Klebsiella pneumoniae
- PMID: 3882593
- DOI: 10.1017/s0195941700062639
The epidemiology of nosocomial infections caused by Klebsiella pneumoniae
Abstract
Klebsiella pneumoniae causes serious epidemic and endemic nosocomial infections. We conducted a literature review to characterize the epidemiology of epidemic K. pneumoniae outbreaks. Eighty percent of the outbreaks (20/25) involved infections of the bloodstream or urinary tract. Person-to-person spread was the most common mode of transmission, and nearly 50% of the outbreaks occurred in neonatal intensive care units. No one serotype predominated, and no association was found between serotype and either the site of infection or antimicrobial susceptibility pattern. We used data reported to the Centers for Disease Control (CDC) by hospitals participating in the National Nosocomial Infections Study (NNIS) to describe the epidemiology of endemic K. pneumoniae infections. In the 8-year period from 1975 through 1982 the nosocomial K. pneumoniae infection rate was 16.7 infections per 10,000 patients discharged. The rate of infection at medical school-affiliated hospitals was significantly greater than at nonaffiliated hospitals; furthermore, the rate of infection at large affiliated hospitals was greater than at small affiliated hospitals. The rate of infection varied by service, with the highest rate found on the medicine service. During the 8-year period, 184 deaths were caused by nosocomial K. pneumoniae infections (184 deaths/16,969 infections, case-fatality ratio 1.1%), with higher ratios in pediatrics (5%) where there was a 12% mortality in children infected with an aminoglycoside-resistant strain.
Similar articles
-
Risk factors associated with a cluster of urinary tract infections in a geriatric unit caused by Klebsiella pneumoniae resistant to multiple antibiotics.Am J Infect Control. 1988 Apr;16(2):66-71. doi: 10.1016/0196-6553(88)90080-6. Am J Infect Control. 1988. PMID: 3288014 No abstract available.
-
Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System.Infect Control Hosp Epidemiol. 1997 Jul;18(7):492-8. doi: 10.1086/647654. Infect Control Hosp Epidemiol. 1997. PMID: 9247832
-
Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.Ann Intern Med. 1993 Sep 1;119(5):353-8. doi: 10.7326/0003-4819-119-5-199309010-00001. Ann Intern Med. 1993. PMID: 8135915
-
The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.Future Microbiol. 2015;10(6):1063-75. doi: 10.2217/fmb.15.22. Future Microbiol. 2015. PMID: 26059626 Review.
-
Antimicrobial Resistance of Hypervirulent Klebsiella pneumoniae: Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms.Front Cell Infect Microbiol. 2017 Nov 21;7:483. doi: 10.3389/fcimb.2017.00483. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 29209595 Free PMC article. Review.
Cited by
-
Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):679-689. doi: 10.1007/s10096-017-3160-z. Epub 2017 Dec 14. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29238932
-
Structural and population characterization of MrkD, the adhesive subunit of type 3 fimbriae.J Bacteriol. 2013 Dec;195(24):5602-13. doi: 10.1128/JB.00753-13. Epub 2013 Oct 11. J Bacteriol. 2013. PMID: 24123820 Free PMC article.
-
Klebsiella pneumoniae triggers a cytotoxic effect on airway epithelial cells.BMC Microbiol. 2009 Aug 3;9:156. doi: 10.1186/1471-2180-9-156. BMC Microbiol. 2009. PMID: 19650888 Free PMC article.
-
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing.Sci Transl Med. 2012 Aug 22;4(148):148ra116. doi: 10.1126/scitranslmed.3004129. Sci Transl Med. 2012. PMID: 22914622 Free PMC article.
-
Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia.J Immunol. 2012 Jul 1;189(1):304-11. doi: 10.4049/jimmunol.1103196. Epub 2012 May 25. J Immunol. 2012. PMID: 22634613 Free PMC article.